EY launches technologydriven solution for life sciences industry

EY has announced the launch of EY Smart Reviewer, a new technology-driven solution for the life sciences industry. It leverages artificial intelligence (AI) and natural language processing to help accelerate and improve the process to review materials used to market pharmaceutical and medical device products. The EY Smart Reviewer solution makes it possible for pharmaceutical and medical technology companies to automate the Medical, Legal, Regulatory Review ( MLR) process and significantly shorten review and approval timelines for modular content, thus driving faster speed to market for essential medicines. It increases speed by eliminating key manual tasks and automating the remaining tasks and it reduces costs by freeing up high-value people to focus on higher value-adding omnichannel activities, while lowering risk of regulatory fines.